A tighter archive for life-science signals.
Search once, then narrow by source or topic.
UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
FDA may consider Moderna's flu vaccine in a narrower group
FDA may consider Moderna's flu vaccine in a narrower group
Prasad overruled vaccine review team, office director on Moderna flu shot
Prasad overruled vaccine review team, office director on Moderna flu shot
Moderna dips on flu vaccine RTF letter
Moderna dips on flu vaccine RTF letter
FDA refuses to review Moderna’s mRNA flu vaccine
FDA refuses to review Moderna’s mRNA flu vaccine
Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Moderna accuses FDA of shifting standard as agency refuses flu shot review
Moderna accuses FDA of shifting standard as agency refuses flu shot review
Chutes & Ladders—Moderna CMO steps down in leadership mix-up
Chutes & Ladders—Moderna CMO steps down in leadership mix-up
Moderna's latest CMO steps down after barely a year
Moderna's latest CMO steps down after barely a year
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
Moderna cancer vaccine holds up; IO Biotech considers a sale
Moderna cancer vaccine holds up; IO Biotech considers a sale
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
Moderna, searching for a rebound, to seek approval of mRNA flu shot
Moderna, searching for a rebound, to seek approval of mRNA flu shot
Moderna seeks flu vaccine approvals; Neumora Alzheimer's data
Moderna seeks flu vaccine approvals; Neumora Alzheimer's data
Moderna gets funding for H5 pandemic influenza vaccine
Moderna gets funding for H5 pandemic influenza vaccine
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page